Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Macrophages modulate mesenchymal stem cell function via tumor necrosis factor alpha in tooth extraction model

Mun AY., Akiyama K., Wang Z., Zhang J., Kitagawa W., Kohno T.

Animal Study with a reported sample of 4 on Chronic Inflammation, Immune Modulation, published in JBMR Plus (2024) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
JBMR Plus (2024)
Reported sample size
4
Source database
Europe PMC
PMID
39086598
PMCID
PMC11289833
DOI
10.1093/jbmrpl/ziae085
Citations
3

Abstract (original English)

Mesenchymal stem cells (MSCs) and macrophages collaboratively contribute to bone regeneration after injury. However, detailed mechanisms underlying the interaction between MSCs and inflammatory macrophages (M1) remain unclear. A macrophage-depleted tooth extraction model was generated in 5-wk-old female C57BL/6J mice using clodronate liposome (12.5 mg/kg/mouse, intraperitoneally) or saline injection (control) before maxillary first molar extraction. Mice were sacrificed on days 1, 3, 5, 7, and 10 after tooth extraction ( n = 4). Regenerated bone volume evaluation of tooth extraction socket (TES) and histochemical analysis of CD80 + M1, CD206 + M2 (anti-inflammatory macrophages), PDGFRα + MSC, and TNF-α + cells were performed. In vitro, isolated MSCs with or without TNF-α stimulation (10 ng/mL, 24 h, n = 3) were bulk RNA-sequenced (RNA-Seq) to identify TNF-α stimulation-specific MSC transcriptomes. Day 7 micro-CT and HE staining revealed significantly lower mean bone volume (clodronate vs control: 0.01 mm 3 vs 0.02 mm 3 , p p + , TNF-α + , PDGFRα + , and CD80 + TNF-α + cells on day 5 (306.5 vs 558.8, p p p p p =.0004; 479.3 vs 384.5, p =.0008; 593.0 vs 473.0, p =.0010, 41.0 vs 32.5, p =.0003). RNA-Seq analysis showed that 15 genes (|log2FC| > 5.0, log2TPM > 5) after TNF-α stimulation were candidates for regulating MSC's immunomodulatory capacity. In vivo, Clec4e and Gbp6 are inv

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research